Dawn Of A New Era? Korean Biopharma M&A Landscape Set For Change
Cash-Rich Pharmas, Conglomerates Hunt For Growth Engines
Mergers and acquisitions are set to gain momentum in South Korea as firms outside the sector seek new growth engines and more open-minded biopharma companies seek rapid growth and globalization.
